Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yingxian Sun has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Chinese expert consensus on the management of blood pressure elevation after acute high-altitude exposure

    by Xiaoping Chen, Lianyou Zhao, Yingxian Sun, Yong Huo, Yuming Li, Jun Cai, Jiguang Wang, Liangdi Xie, Jun Tao, Zhaoqiang Cui, et al.

    Elevated blood pressure following acute high-altitude exposure is a common physiological stress response. However, excessive elevation or improper management may precipitate hypertensive emergencies and increase the risk of cardiovascular and cerebrovascular events. Currently, there is a lack of systematic clinical guidance for blood pressure management in this specific context. To address this gap, the Hypertension Committee of the Chinese Medical Doctor Association convened a multidisciplinary panel of experts to develop this consensus, based on available evidence and clinical practice. This consensus systematically summarizes the characteristics, core pathophysiological mechanisms, and association with acute high-altitude illness of blood pressure elevation after acute high-altitude exposure. It proposes a classification system for the severity of blood pressure elevation and a framework for cardiovascular risk assessment prior to high-altitude exposure. The consensus focuses on the efficacy, safety, and evidence for antihypertensive medications with different mechanisms of action in high-altitude environments. Furthermore, it establishes a clinical management pathway encompassing blood pressure monitoring, high-altitude pre-adaptation, intervention for elevated blood pressure, and management of high-altitude-related hypertensive emergencies. This consensus aims to provide a standardized and practical reference for clinical decision-making, thereby improving the comprehensive management of blood pressure elevation after acute high-altitude exposure.

  • Open Access

    Association between triglyceride glucose-body mass index and new-onset hypertension in the middle-aged and older general population of China: a prospective cohort study

    by Xueyao Zhang, Yingxian Sun

    Cardiovascular and cerebrovascular events and their related deaths, caused by hypertension, pose serious public health challenges on a global scale. As a silent killer, high systolic blood pressure...

  • Open Access

    Global burden of atrial fibrillation/atrial flutter and its attributable risk factors in adolescents and young adults, 1990–2021: insights from the global burden of disease study

    by Xueyao Zhang, Yanli Chen, Wenyu Hu, Saien Lu, Haijie Yu, Yingxian Sun

    The aim of this study is to evaluate the global burden trends of atrial fibrillation/flutter with attributable risk factors among adolescents and young adults from 1990 to 2021, particularly in the context of the increasing prevalence of cardiovascular diseases in younger populations. Disease burden data for atrial fibrillation/atrial flutter were sourced from the 2021 Global Burden of Disease Study. The primary metrics were incidence, disability-adjusted life years, and mortality. Population attributable fractions were used to calculate the percentage contribution of the major underlying risk factors to the disease burden. From 1990 to 2021, the global burden of atrial fibrillation/atrial flutter among the studied population increased by 57.26% in incidence, 71.32% in mortality, and 62.34% in disability-adjusted life years. The rate increases were 15.87%, 26.22%, and 19.61%, respectively. The burden of atrial fibrillation/atrial flutter in 2021 and its temporal trends varied significantly according to sex, sociodemographic index quintiles, and geographic location. In 2021, the burden was the highest in the middle-sociodemographic-index regions. Sex differences were found in all potential risk factors of atrial fibrillation/atrial flutter-related mortality and disability-adjusted life year rates. The top three potential risk factors in men were high systolic blood pressure, tobacco exposure, and high alcohol use, and in women, high systolic blood pressure, high body mass index, and tobacco exposure. An imbalance in disease burden across different regions exists. The rapidly increasing disease burden warrants attention, and prevention and treatment strategies should be adjusted to prevent further increase.


  • Top Cited Papers
    Open Access

    Global, regional, and national disease burden attributable to high systolic blood pressure in youth and young adults: 2021 Global Burden of Disease Study analysis

    by Chuan He, Saien Lu, Haijie Yu, Yingxian Sun, Xueyao Zhang

    High systolic blood pressure (HSBP) can cause adverse cardiovascular events and is therefore associated with a heavy global disease burden. However, this disease burden is poorly understood in youth and young adults. We aimed to explore this population to better understand the evolving trends in HSBP-related disease burden, which is crucial for effectively controlling and mitigating harmful effects. This systematic analysis used data from the 2021 Global Burden of Disease Study, spanning 1990–2021. Participants were aged 15–39 years from 204 countries/territories. We analysed HSBP-related disease burden by region, sex, age, and temporal trends. The primary outcomes were disability-adjusted life years (DALYs), mortality rates, and estimated annual percentage change. Globally, the number of HSBP-related deaths among youth and young adults has increased by 36.11% (95% uncertainty interval [95% UI], 20.96–52.37%), whereas the number of DALYs has increased by 37.68% (95% UI, 22.69–53.65%); however, global mortality and DALY rates have remained relatively stable. In 2021, the mortality and DALY rates were 4.29 (95% UI, 3.29–5.28) and 263.37 (95% UI, 201.40–324.46) per 100,000 population, respectively. The overall HSBP-related burden was higher in males than in females, with increasing and decreasing trends for males and females, respectively. Regionally, significant improvements in HSBP-related burden were observed in most high-sociodemographic index (SDI) regions, including high-income Asia Pacific (deaths: percentage change, − 72.65%; DALYs: percentage change, − 69.30%) and Western Europe (deaths: percentage change, − 72.89%; DALYs: percentage change, − 67.48%). In contrast, middle-SDI regions had the highest number of deaths and DALYs in 2021, whereas low-middle-SDI regions had the highest mortality and DALY rates. Furthermore, low-SDI regions experienced the largest increase in the number of deaths and DALYs. The HSBP-related burden increased with age; in addition, the proportion of deaths or DALYs due to ischaemic heart disease and stroke increased with age, reaching > 75% for those > 25 years of age. The increase in global HSBP-related burden among youth and young adults indicates that current preventative efforts are insufficient. Therefore, targeted measures are needed to counter the trends in HSBP-related diseases and reduce disparities across regions and sexes.


  • Open Access

    Progress in diagnosis and treatment of hypertension combined with left ventricular hypertrophy

    by Yongjin Han, Yanqiu Li, Zhen Wu, Ying Pei, Saien Lu, Haijie Yu, Yingxian Sun, Xueyao Zhang

    Hypertension, a worldwide cardiovascular issue, is known to result in significant damage to the left ventricle. Left ventricular hypertrophy refers to an increase in ventricular mass, which is not only the primary independent risk factor for cardiovascular disease onset but also independently related to the risk of death. We sought to synthesize the existing literature on the occurrence and correlation between hypertension and left ventricular hypertrophy and the progress. A scoping review was performed based on the methodological framework developed by Arksey & O'Malley. Search in the Pubmed database with no language restrictions, as of September 1, 2024. Of the 8110 articles retrieved, 110 were finally included. The selected articles were published between 1987 and 2024, with 55.5% (61/110) of the studies in the last five years and 14.5% (16/110) of 2024. The studies covered diagnosis, epidemiology, pathophysiology, prognosis, and treatment of hypertension with left ventricular hypertrophy. The literature reviewed suggests that studies on hypertension combined with left ventricular hypertrophy covered a variety of clinical progress, especially the clinical trial results of some new drugs that may bring great hope for treatment.


  • Open Access

    Construction and validation of a nomogram to predict left ventricular hypertrophy in low‐risk patients with hypertension

    by Xueyao Zhang, Chuan He, Saien Lu, Haijie Yu, Guangxiao Li, Pengyu Zhang, Yingxian Sun

    Electrocardiography (ECG) is an accessible diagnostic tool for screening patients with hypertensive left ventricular hypertrophy (LVH). However, its diagnostic sensitivity is low, with a high probability of false-negatives. Thus, this study aimed to establish a clinically useful nomogram to supplement the assessment of LVH in patients with hypertension and without ECG-LVH based on Cornell product criteria (low-risk hypertensive population). A cross-sectional dataset was used for model construction and divided into development (n = 2906) and verification (n = 1447) datasets. A multivariable logistic regression risk model and nomogram were developed after screening for risk factors. Of the 4353 low-risk hypertensive patients, 673 (15.4%) had LVH diagnosed by echocardiography (Echo-LVH). Eleven risk factors were identified: hypertension awareness, duration of hypertension, age, sex, high waist-hip ratio, education level, tea consumption, hypochloremia, and other ECG-LVH diagnostic criteria (including Sokolow-Lyon, Sokolow-Lyon products, and Peguero-Lo Presti). For the development and validation datasets, the areas under the curve were 0.724 (sensitivity = 0.606) and 0.700 (sensitivity = 0.663), respectively. After including blood pressure, the areas under the curve were 0.735 (sensitivity = 0.734) and 0.716 (sensitivity = 0.718), respectively. This novel nomogram had a good predictive ability and may be used to assess the Echo-LVH risk in patients with hypertension and without ECG-LVH based on Cornell product criteria.


  • Open Access

    Influence of hypertension and global or abdominal obesity on left ventricular hypertrophy: A cross‐sectional study

    by Xueyao Zhang, Guangxiao Li, Dongyuan Zhang, Yingxian Sun

    Although hypertension and obesity are both risk factors for left ventricular hypertrophy (LVH), the extent of their impact on LVH in the general population is still unclear, and the predictive value of obesity indicators for LVH remains to be elucidated. In this study, obesity‐related indicators, including waist circumference (WC), waist‐height ratio (WHTR), and waist‐hip ratio (WHR), were used to define abdominal obesity (AO), whereas body mass index (BMI) was used to measure general obesity (GO). The effects of hypertension and obesity on LVH were estimated using logistic regression analysis, as was the relative risk of LVH based on the presence of obesity, hypertension, or both. Subgroup analyses were performed based on sex and age. Of the 9134 participants (≥35 years old), 915 (10.0%) developed LVH. After adjusting for covariates, the odds ratios (95% confidence intervals) for LVH were 3.94 (3.27–4.75) in patients with hypertension, 1.90 (1.60–2.26) in those with GO, and 1.45 (1.25–1.69), 1.69 (1.43–2.00), and 1.54 (1.33–4.75) in individuals with AO defined based on WC, WHTR, and WHR, respectively. Analysis by sex showed similar values in women, but AO based on WC and WHR were not significantly associated with LVH in men. Further, after adjusting for potential confounding factors, concomitant hypertension and obesity had an increased risk of developing LVH in all age ranges, particularly in patients aged 35–45 years (risk increased 14.14‐fold, 10.84‐fold, 7.97‐fold, and 9.95‐fold for BMI‐based GO and WC‐, WHTR‐, and WHR‐based AO, respectively), and in both men and women but particularly in men (risk increased 7.71‐fold, 4.67‐fold, 5.83‐fold, and 5.58‐fold, respectively). In summary, all obesity indicators (BMI, WC, WHTR, and WHR) had predictive value for LVH in women; however, only BMI and WHTR should be considered for men. Furthermore, monitoring for the occurrence and progression of LVH is imperative for rural Chinese patients with concomitant hypertension and obesity, especially men and those aged 35–45 years.


  • Open Access

    Associations of sleep duration, daytime napping, and snoring with depression in rural China: a cross-sectional study

    by Xueyao Zhang, Guangxiao Li, Chuning Shi, Yingxian Sun

    Background: Most adult patients with depression complain about sleep symptoms, including insufficient and excessive sleep. However, previous studies investigating the impact of sleep duration on depression have yielded conflicting results. Therefore, this study aimed to analyse the link between depression and sleep duration, daytime napping, and snoring among rural Chinese adults. Methods: A cross-sectional study was conducted with 9104 individuals. Interviews were conducted with the participants regarding their sleep patterns and their daytime napping routines. The individuals were then assessed for depression using the Patient Health Questionnaire-9. The risk of depression was assessed using a multifactor binary logistic regression analysis. A generalized additive model was used to evaluate the nonlinear relationship between depression and sleep duration/nap time. Additionally, subgroup analysis was conducted to investigate the correlation between sleep duration, daytime napping, snoring, and depression. Results: Less than 6 h or more than 8 h of nighttime sleep, daytime napping for more than 1 h, and snoring were all significantly associated with an increased risk of depression. A U-shaped relationship was found between the duration of nighttime sleep and depression. In addition, we found that the nighttime duration of sleep, daytime naps, and snoring had a significant combined effect on the risk of depression. The subgroup analysis further revealed that lack of sleep at night significantly increased the risk of depression in all subgroups. However, snoring and excessive nighttime sleep and napping were only associated with the risk of depression in some subgroups. Conclusions: Lack of nighttime sleep (short sleep duration), excessive sleep, and napping for more than one hour during the day were associated with a high risk of depression and had a combined effect with snoring.


  • Open Access

    Comparison of conventional and unconventional obesity indices associated with new-onset hypertension in different sex and age populations

    by Xueyao Zhang, Guangxiao Li, Chuning Shi, Yichen Tian, Linlin Zhang, Hongyu Zhang, Yingxian Sun

    We aimed to compare the relationship between hypertension and obesity-related anthropometric indices (waist circumference [WC], waist-height ratio, waist-hip ratio [WHR], and body mass index; unconventional: new body shape index [ABSI] and body roundness index [BRI]) to identify best predictors of new-onset hypertension. The study included 4123 adult participants (2377 women). Hazard ratios (HRs) and 95% confidence intervals (CIs) were determined using a Cox regression model to estimate the risk of new-onset hypertension with respect to each obesity index. In addition, we assessed the predictive value of each obesity index for new-onset hypertension using area under the receiver operating characteristic curve (AUC) after adjusting for common risk factors. During the median follow-up of 2.59 years, 818 (19.8%) new hypertension cases were diagnosed. The non-traditional obesity indices BRI and ABSI had predictive value for new-onset hypertension; however, they were not better than the traditional indexes. WHR was the best predictor of new-onset hypertension in women aged ≤ 60 and > 60 years, with HRs of 2.38 and 2.51 and AUCs of 0.793 and 0.716. However, WHR (HR 2.28, AUC = 0.759) and WC (HR 3.24, AUC = 0.788) were the best indexes for predicting new-onset hypertension in men aged ≤ 60 and > 60 years, respectively.


  • Open Access

    A nomogram including serum ions to screen for new-onset hypertension in rural Chinese populations over a short-term follow-up period: a prospective cohort study

    by Xueyao Zhang, Guangxiao Li, Chuning Shi, Yingxian Sun

    Background: This study aimed to establish a clinically useful nomogram to evaluate the probability of hypertension onset in a Chinese population. Methods: A prospective cohort study was conducted in 2012/2013, and followed up in 2015 to identify new-onset hypertension in 4123 participants. The dataset was divided into development (n=2748) and verification (n=1375) cohorts. After screening risk factors by lasso regression, a multivariate Cox regression risk model as well as a nomogram were established. Results: Among 4123 patients, 818 (19.8%) developed hypertension. The model identified 10 risk factors: age, waist-to-hip ratio, systolic blood pressure, diastolic blood pressure, high pulse rate, history of diabetes mellitus, family history of hypertension and stroke, intake frequency of bean products, and physical labour intensity. The C-indexes of this model were 0.744 and 0.768 in the development and validation cohorts, respectively. After the inclusion of serum calcium and magnesium levels, the C-indexes were 0.764 and 0.791, respectively. The areas under the curve of the updated model in the development and validation cohorts were 0.907 and 0.917, respectively. The calibration curve showed that the nomogram predicted the hypertension probability accurately. The updated nomogram was clinically beneficial across thresholds of 10%–60%. Conclusions: The newly developed nomogram has good predictive ability and may effectively assess hypertension risk in high-risk rural areas in China.